Argenx Se (ARGX) Research & Development (2016 - 2026)
Argenx Se's Research & Development came in at -$486 million for Q2 2026, compared with -$327.7 million a year earlier.
Powered by 
Analysis
Argenx Se (ARGX) Research & Development (2016 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Argenx Se reported Research & Development of -$1.66 billion; for FY2025, it was -$1.36 billion.
- Going back by year, Research & Development was -$983.42 million in FY2024, -$859.49 million in FY2023, -$663.37 million in FY2022 and -$580.52 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly Research & Development in data going back to Q3 2016.
- Business Quant data shows ARGX's Research & Development at -$443 million (Q1 2026), -$371.71 million (Q4 2025) and -$355.65 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Argenx Se | 50.23 Bn | 34.19 Bn | 1.37 Bn | 1.37 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.37 Bn |
| Mar 31, 2026 | -443.00 Mn |
| Dec 31, 2025 | -371.71 Mn |
| Sep 30, 2025 | -355.65 Mn |
| Jun 30, 2025 | -327.70 Mn |
| Mar 31, 2025 | -311.00 Mn |
| Dec 31, 2024 | -297.23 Mn |
| Sep 30, 2024 | -235.94 Mn |
| Jun 30, 2024 | -225.29 Mn |
| Mar 31, 2024 | -224.97 Mn |
| Dec 31, 2023 | -306.37 Mn |
| Sep 30, 2023 | -191.76 Mn |
| Jun 30, 2023 | 527.22 Mn |
| Mar 31, 2023 | -165.86 Mn |
| Dec 31, 2022 | -147.80 Mn |
| Sep 30, 2022 | -236.68 Mn |
| Jun 30, 2022 | -126.92 Mn |
| Mar 31, 2022 | -151.97 Mn |
| Dec 31, 2021 | -167.17 Mn |
| Sep 30, 2021 | -139.44 Mn |
API Access
Argenx Se Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ARGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ARGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ARGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();